There are 2789 resources available
LBA54 - Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)
Presenter: Alexander Stein
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA55 - Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen
Presenter: Eric Van Cutsem
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
1373MO - JUPITER-06: A randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC)
Presenter: Rui-Hua Xu
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA10 - Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group
Presenter: Lukas Perkhofer
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA52 - Sintilimab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced or metastatic esophageal squamous cell cancer: First results of the phase III ORIENT-15 study
Presenter: Lin Shen
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Discussion LBA52, LBA53, LBA54 and LBA55
Presenter: Yelena Janjigian
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Discussion 960MO, 961MO and 962MO
Presenter: Thomas Gajewski
Session: Mini oral session - Investigational immunotherapy
Resources:
Slides
Webcast
Discussion 1373MO, LBA10 and LBA37
Presenter: Changhoon Yoo
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Yes
Presenter: Jonas Bergh
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast